Skip to main content
ACS Omega logoLink to ACS Omega
. 2021 Nov 19;6(48):33239. doi: 10.1021/acsomega.1c06159

Retraction of “Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis”

Yanqiao Wu, Nagaraja Sreeharsha, Sanjay Sharma, Anurag Mishra , Avinash Kumar Singh, Shiva Kumar Gubbiyappa
PMCID: PMC8656203  PMID: 34901676

The Editors retract this Article due to concerns about the reliability and reproducibility of the published data. Concerns have been raised surrounding the experimental design including the comparison of animals treated with rosiglitazone. These concerns are significant enough to cast doubts on the main findings of the work.

The original Article was published on March 4, 2020, and retracted on November 19, 2021.


Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES